CompletedPhase 3NCT00981942

Treatment of Patients With Nephrogenic Systemic Fibrosis With Glivec

Studying Nephrogenic systemic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Aarhus
Principal Investigator
Anne B Olesen, MD,PhD, P.A
Anne Braae Olesen
Intervention
Imatinib mesylate (Glivec)(drug)
Enrollment
10 enrolled
Eligibility
18 years · All sexes
Timeline
20092010

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00981942 on ClinicalTrials.gov
← Back to all trials